Zhirong Zhang
- Pharmaceutical Science top 0.02%
- Advanced Drug Delivery Systems 78
- Drug Solubulity and Delivery Systems 29
- Biomaterials top 0.05%
- Nanoparticle-Based Drug Delivery 133
- Biomedical Engineering top 0.2%
- Nanoplatforms for cancer theranostics 89
- Molecular Medicine top 0.5%
- Molecular Biology top 0.5%
- RNA Interference and Gene Delivery 117
- Advanced biosensing and bioanalysis techniques 39
- Lipid Membrane Structure and Behavior 27
-
- Immunotherapy and Immune Responses 45
- Journals
- Journal of Controlled Release (40 papers)International Journal of Pharmaceutics (32 papers)ACS Applied Materials & Interfaces (26 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Zhirong Zhang
510 papers receiving 18.9k citations
Hit Papers
Peers
Comparison fields: 5 of 179
- Pharmaceutical Science 3.4k
- Biomaterials 6.0k
- Biomedical Engineering 5.3k
- Molecular Medicine 591
- Molecular Biology 8.2k
Countries citing papers authored by Zhirong Zhang
This map shows the geographic impact of Zhirong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhirong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhirong Zhang more than expected).
Fields of papers citing papers by Zhirong Zhang
This network shows the impact of papers produced by Zhirong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhirong Zhang. The network helps show where Zhirong Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhirong Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 13 | |
| 4 | 2023 | 60 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 36 | |
| 8 | 2021 | 50 | |
| 9 | Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritisbreakdown → | 2021 | 195 |
| 10 | 2021 | 15 | |
| 11 | 2018 | 24 | |
| 12 | Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's diseasebreakdown → | 2018 | 446 |
| 13 | 2017 | 22 | |
| 14 | 2017 | 115 | |
| 15 | 2016 | 62 | |
| 16 | Simultaneous determination of 12 elements extraction from ceramic articles in contact with foodstuffs by inductively coupled plasma-mass spectrometry. | 2016 | 1 |
| 17 | 2014 | 68 | |
| 18 | Comparison of HPLC chromatographic profiles of fresh and dry pine needle of Pinus massoniana | 2013 | 1 |
| 19 | Enhanced oral bioavailability of salvianolic acid B by phospholipid complex loaded nanoparticles. | 2008 | 32 |
| 20 | Determination of tetramethylpyrazine phosphate in dog plasma by RP-HPLC | 2003 | 1 |
About Zhirong Zhang
Zhirong Zhang is a scholar working on Pharmaceutical Science, Biomaterials and Complementary and alternative medicine, having authored 525 papers that have together received 19.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (133 papers), RNA Interference and Gene Delivery (117 papers), Nanoplatforms for cancer theranostics (89 papers), Advanced Drug Delivery Systems (78 papers), Immunotherapy and Immune Responses (45 papers), Advanced biosensing and bioanalysis techniques (39 papers), Drug Solubulity and Delivery Systems (29 papers) and Lipid Membrane Structure and Behavior (27 papers). The work is most often cited by research in Pharmaceutical Science (3.4k citations), Biomaterials (6.0k citations) and Biomedical Engineering (5.3k citations). Zhirong Zhang has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Tao Gong, Xun Sun, Yuan Huang, Qin He, Yao Fu, Xun Sun, Man Li, Wenfei Chen, Wei Shan and Xi Zhu. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, ACS Applied Materials & Interfaces, Molecular Pharmaceutics and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.